$DNDN Dendreon Corp (DNDN) Overall Average: 24% Buy. Monday,

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Currax Pharmaceuticals Achieves Remarkable Growth in 2024 Currax Pharmaceuticals LLC, a leading specialty pharmaceutical company, has recently announced outstanding financial and operational performance for the year. Fueled by a significant increase in the global demand for its flagship products CONTRAVE and MYSIMBA, the company has reported over 50% growth in revenue for...

Anticipating Amazon's Q3 Earnings Report Amazon.com Inc (NASDAQ: AMZN) is on the brink of revealing its third-quarter financial performance, a moment that could reflect the company's resilience amidst recent challenges. With a backdrop dominated by headlines of job cuts and an AWS outage, analysts are keenly observing what the earnings report will unveil. This article...

Melco Resorts Finance Announces Senior Notes Offering Melco Resorts Finance Limited has taken an important step with its recent announcement regarding a new senior notes offering. This offering, valued at a substantial US$500 million, aims to bolster the financial stability and operational capabilities of Melco Resorts Finance, a key subsidiary of Melco Resorts &...

Understanding the Buzz Around Bloom Energy Options In the world of stock trading, Bloom Energy (NYSE: BE) is currently capturing the attention of investors with its recent options trading activity. Wealthy investors are increasingly adopting a bullish stance, making this a key moment for market participants to analyze. The stark changes in option trading volumes have...

Pharvaris Announces Major Public Offering Pharvaris N.V. (NASDAQ: PHVS) has recently revealed its plans for a significant public offering aimed at raising approximately $175 million. This offering is primarily focused on the company's ordinary shares and pre-funded warrants. Details of the Offering The offering comprises a total of 8,250,000 ordinary shares priced at...